Amorcyte Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
Amorcyte General Information
Description
Developer of cell therapy products to treat cardiovascular diseases. The company's products include AMR-001, a bone marrow derived CD 34 positive selected stem cell product for the treatment of damaged heart muscle following acute myocardial infarction.
Contact Information
Website
www.amorcyte.comCorporate Office
- Four Pearl Court
- Suite C
- Allendale, NJ 07401
- United States
Corporate Office
- Four Pearl Court
- Suite C
- Allendale, NJ 07401
- United States
Amorcyte Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Amorcyte Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Amorcyte FAQs
-
When was Amorcyte founded?
Amorcyte was founded in 2005.
-
Where is Amorcyte headquartered?
Amorcyte is headquartered in Allendale, NJ.
-
What industry is Amorcyte in?
Amorcyte’s primary industry is Biotechnology.
-
Is Amorcyte a private or public company?
Amorcyte is a Private company.
-
What is the current valuation of Amorcyte?
The current valuation of Amorcyte is .
-
What is Amorcyte’s current revenue?
The current revenue for Amorcyte is .
-
How much funding has Amorcyte raised over time?
Amorcyte has raised $6.88M.
-
Who are Amorcyte’s investors?
Colt Ventures and Novitas Capital have invested in Amorcyte.
-
When was Amorcyte acquired?
Amorcyte was acquired on 17-Oct-2011.
-
Who acquired Amorcyte?
Amorcyte was acquired by Lisata Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
